GMP Cell Therapy and Vector Core
GMP 细胞疗法和载体核心
基本信息
- 批准号:8555387
- 负责人:
- 金额:$ 53.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-22 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus VectorAreaBasic ScienceBlood CellsBlood Component RemovalBone MarrowCalibrationCancer CenterCardiovascular systemCell SeparationCell TherapyCell physiologyCellsChemistryClinicalClinical ResearchClinical TrialsCodeContractsDendritic CellsDisadvantagedDocumentationDoseEngraftmentEnsureEnvironmental MonitoringEquipmentGene-ModifiedGenerationsGenesGoalsGuanosine TriphosphateHematopoieticHousingImmuneInstitutionInternationalInvestigational DrugsInvestigational New Drug ApplicationLaboratoriesLaboratory StudyMaintenanceMedicineMonitorNational Heart, Lung, and Blood InstitutePatientsPhasePhysiologic pulsePreparationProceduresProcessProductionProgram Research Project GrantsProtocols documentationQuality ControlRecordsRegulationReportingResearch InfrastructureResearch PersonnelResource SharingRetroviral VectorServicesSomatic CellSourceStem cellsStructureSystemT-LymphocyteTestingTherapeuticTherapeutic StudiesTissuesTrainingTranslationsTransplantationTumor-Infiltrating LymphocytesUmbilical Cord BloodUmbilical Cord Blood TransplantationUnited States Food and Drug AdministrationViral Tumor AntigensViral VectorVirusWorkcell preparationcold temperaturecollegeexperiencegene therapyimprovedmanufacturing facilitynanoparticleoperationpreclinical studyprogramsquality assurancereconstitutionstemvector
项目摘要
This Program Project Grant (PO1) explores the enhancement of cord blood transplantation by employing ex-vivo expansion of cord blood stem/progenitor and T cells in preclinical studies and clinical trials. All four projects will undertake clinical trials during the course of the studies. These rely on the availability of a GMP manufacturing facility for the preparation of the cellular therapy products and associated viral vectors. Projects 1 and 4 will use on the Good Manufacturing Practice (GMP) Facility at MD Anderson Cancer Center (MDACC) and Projects 2 and 3 will rely on the GMP facility and the Clinical Vector Production Facility at the Center for Cell and Gene Therapy Baylor College of Medicine (BCM). The GMP Facilities at BCM and MDACC have been in operation for more than 10 years. The Cell Processing Facilities at both institutions have considerable experience in the preparation of a wide variety of cellular products, including all that would be required for the Projects in this application. Both facilities consist of HEPA filtered. Class 10,000 space divided into multiple cell preparation laboratories, low temperature storage areas, cell sorting and analysis laboratories, large equipment areas and central supply facilities. Both Facilities are well equipped to operate under GMP conditions, with extensive documentation systems, barcoding, environmental monitoring and quality assurance, control and improvement programs. Additional components of the Core are the Quality Control Laboratories at BCM and MDACC, which perform in-house testing of cellular products (and vectors), and are responsible for routine monitoring of Good Manufacturing Practices; and the Quality Assurance Group to ensure compliance with GMP and provides independent overview of all aspects of manufacturing and release. The Clinical Vector Production Facility at BCM, which is also a part of the Core, has produced more than 30 clinical grade adenovectors and retroviral vectors for local, national and international studies. The GMP staff at both institutions have extensive regulatory experience that will facilitate the translational of laboratory studies into clinical trials. In summary, the GMP Laboratory Core is a vital component of the P01 that will provide essential services to the implementation of the clinical studies in Projects 1, 2, 3 and 4.
该计划项目资助(PO 1)探索通过在临床前研究和临床试验中采用脐带血干/祖细胞和T细胞的体外扩增来增强脐带血移植。所有四个项目将在研究过程中进行临床试验。这些依赖于GMP生产设施的可用性,用于制备细胞治疗产品和相关病毒载体。项目1和4将使用MD安德森癌症中心(MDACC)的药品生产质量管理规范(GMP)设施,项目2和3将依赖于细胞和基因治疗中心贝勒医学院(Baylor College of Medicine)的GMP设施和临床载体生产设施。位于上海市浦东新区和上海浦东新区的GMP设施已经运行了10多年。这两个机构的细胞处理设施在制备各种细胞产品方面具有相当丰富的经验,包括本申请项目所需的所有产品。这两个设施都由HEPA过滤器组成。10,000级空间分为多个细胞制备实验室、低温储存区、细胞分选和分析实验室、大型设备区和中央供应设施。这两个工厂都配备了良好的GMP条件下运行,广泛的文件系统,条形码,环境监测和质量保证,控制和改进计划。核心的其他组成部分是位于ESTA和MDACC的质量控制实验室,其对细胞产品(和载体)进行内部检测,并负责对药品生产质量管理规范进行常规监测;以及质量保证组,以确保符合GMP,并对生产和放行的所有方面提供独立的概述。临床载体生产设施也是核心的一部分,已经为地方、国家和国际研究生产了30多个临床级腺病毒载体和逆转录病毒载体。两个机构的GMP工作人员具有丰富的监管经验,这将有助于将实验室研究转化为临床试验。总之,GMP实验室核心是P01的重要组成部分,将为项目1、2、3和4中临床研究的实施提供必要服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADRIAN Philip GEE其他文献
ADRIAN Philip GEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADRIAN Philip GEE', 18)}}的其他基金
Path to Commercialization of the first “off the shelf” T cell product
第一个“现成”T 细胞产品的商业化之路
- 批准号:
9301696 - 财政年份:2017
- 资助金额:
$ 53.46万 - 项目类别:
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Standard Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Major Research Instrumentation
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Research Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427231 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Standard Grant